8 completed. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Embryonal Childhood Rhabdomyosarcoma: new trials by email Literature Review of Embryonal Childhood Rhabdomyosarcoma trials Research Report on Embryonal Childhood Rhabdomyosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retrospective Study in FFPE Samples From Younger Patients With Rhabdomyosarcoma Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma | Completed | Shandong First Medical University | 6 | 2023-04-01 | 2023-09-15 | |
| Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma laboratory biomarker analysis - Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma | Completed | Children's Oncology Group | 20 | 2012-06-01 | 2016-07-14 | |
| Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma laboratory biomarker analysis - Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma | Completed | Children's Oncology Group | 99 | 2012-06-01 | 2016-05-18 | |
| Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma laboratory biomarker analysis - Alveolar Childhood Rhabdomyosarcoma, Childhood Rhabdomyosarcoma | Completed | Children's Oncology Group | 77 | 2011-12-01 | 2016-05-19 | |
| Ixabepilone in Treating Young Patients With Refractory Solid Tumors ixabepilone - Adult Rhabdomyosarcoma, Adult Synovial Sarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 120 | 2006-04-01 | 2014-11-14 |
| Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma conventional surgery, dactinomycin, cyclophosphamide - Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma | Phase 3 | Completed | Children's Oncology Group | 390 | 2004-09-04 | 2021-11-19 |
| Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma dactinomycin, vincristine sulfate, cyclophosphamide - Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma | Phase 3 | Completed | Children's Oncology Group | 702 | 2002-09-01 | 2013-06-17 |
| Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma vincristine sulfate, irinotecan hydrochloride, cyclophosphamide - Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 150 | 2001-11-01 | 2013-01-17 |
Rhabdomyosarcoma (3) · Sarcoma (2) · Malignant mesenchymal tumor (1) · Neuroblastoma (1) · Neuroectodermal Tumors, Primitive, Peripheral (1) · Osteosarcoma (1) · Sarcoma, Synovial (1) · Wilms Tumor (1)
Myosarcoma (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Muscle Tissue (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Kidney Diseases (1) · Kidney Neoplasms (1) · Male Urogenital Diseases (1) · Neoplasms by Site (1) · Neoplasms, Bone Tissue (1) · Neoplasms, Complex and Mixed (1)
Cyclophosphamide (3) · Vincristine (3) · Dactinomycin (2) · Filgrastim (2) · Granulocyte Colony-Stimulating Factor (2) · Granulocyte-Macrophage Colony-Stimulating Factor (2) · Radiation (2) · Radiotherapy (2) · sargramostim (2) · Congresses as Topic (1) · Doxorubicin (1) · Etoposide (1) · Ifosfamide (1) · Irinotecan (1) · Pharmacogenomic Testing (1)
Children's Oncology Group (5) · National Cancer Institute (NCI) (2) · Shandong First Medical University (1)
United States (7) · Australia (1) · Canada (1) · China (1) · New Zealand (1) · Puerto Rico (1) · Switzerland (1)
Brigitte Widemann (1) · Carola Arndt (1) · Christopher Pelloski, MD (1) · David Walterhouse, MD (1) · Frederick Barr, MD (1) · Lee Helman, MD (1) · Philip Breitfeld (1) · Tao Xu (1)
U10CA098543 (4)